# The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes

Study · id `cardio:ct-nct01795248` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01795248](<https://clinicaltrials.gov/study/NCT01795248>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01795248

Browse, organ or system: Metabolism  
Browse, condition area: Diabetes and metabolic disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 105 participants.

## Technical summary

Registry record NCT01795248. Randomized; triple masking; primary purpose prevention. Start 2012-07 (actual); primary completion 2019-09 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 105 participants (enrolled count; ClinicalTrials.gov record NCT01795248, source copy `cardio:ctgov-nct01795248-2020-11-04`, retrieved 2026-10-26)
- Started: 2012-07 (actual) (ClinicalTrials.gov record NCT01795248, source copy `cardio:ctgov-nct01795248-2020-11-04`, retrieved 2026-10-26)
- Primary completion: 2019-09 (actual) (ClinicalTrials.gov record NCT01795248, source copy `cardio:ctgov-nct01795248-2020-11-04`, retrieved 2026-10-26)
- Completion: 2020-09 (actual) (ClinicalTrials.gov record NCT01795248, source copy `cardio:ctgov-nct01795248-2020-11-04`, retrieved 2026-10-26)
- Countries: Denmark (ClinicalTrials.gov record NCT01795248, source copy `cardio:ctgov-nct01795248-2020-11-04`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01795248-2020-11-04`, retrieved 2026-10-26)

## The registry's words

- Brief title: The Impact of Liraglutide on Glucose Tolerance and the Risk of Type 2 Diabetes in Women With Previous Pregnancy-induced Diabetes
- Condition: Gestational Diabetes Mellitus
- Intervention (Drug): Liraglutide
- Intervention (Drug): Placebo
- Lead sponsor: Tina Vilsboll
- Lead sponsor class: OTHER
- Collaborator: Novo Nordisk A/S
- Collaborator class: INDUSTRY
- Collaborator: Copenhagen University Hospital, Rigshospitalet
- Collaborator class: OTHER
- Collaborator: Hvidovre University Hospital
- Collaborator class: OTHER
- Collaborator: Herlev Hospital
- Collaborator class: OTHER
- Collaborator: Hillerod Hospital, Denmark
- Collaborator class: OTHER
- Collaborator: University of Copenhagen
- Collaborator class: OTHER
- Collaborator: The Novo Nordisk Foundation Center for Basic Metabolic Research
- Collaborator class: OTHER
- Collaborator: Aarhus University Hospital
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Type 2 diabetes (`cardio:type-2-diabetes`)
- Registry lists this organization as a collaborator: Novo Nordisk (`cardio:novo-nordisk`)
- Registry lists this organization as a collaborator: Copenhagen University Hospital, Rigshospitalet (`cardio:org-copenhagen-university-hospital-rigshospitalet`)
- Registry lists this organization as a collaborator: Hvidovre University Hospital (`cardio:org-hvidovre-university-hospital`)
- Registry lists this organization as a collaborator: Herlev Hospital (`cardio:org-herlev-hospital`)
- Registry lists this organization as a collaborator: Hillerod Hospital, Denmark (`cardio:org-hillerod-hospital-denmark`)
- Registry lists this organization as a collaborator: University of Copenhagen (`cardio:org-university-of-copenhagen`)
- Registry lists this organization as a collaborator: Aarhus University Hospital (`cardio:org-aarhus-university-hospital`)

## Provenance

Content hash: cbac12809d7ab4197d5216488b948e949b6d099e483cf10c88e8c9f36f82b001
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
